InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Interest Expenses (2016 - 2026)

InflaRx's (IFRX) quarterly Interest Expenses came in at -$17020.5 in Q2 2026, down 348.18% year-over-year from $6858.2 in Q2 2025, and up 1.83% quarter-over-quarter from -$17337.6 in Q1 2026.

Analysis

InflaRx (IFRX) Interest Expenses (2016 - 2026) Analysis & Trends

InflaRx has disclosed Interest Expenses across 11 years of filings, most recently posting -$17020.5 for Q2 2026.

  • In Q2 2026, Interest Expenses fell 348.18% year-over-year to -$17020.5; the TTM figure through Jun 2026 stood at -$71444.3 (down 100.16% YoY), while the FY2025 annual figure was -$44332.7, down 100.86% from the prior year.
  • Interest Expenses came in at -$17020.5 for Q2 2026 at InflaRx, up from -$17337.6 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of -$3797.7 in Q2 2025 to a low of -$46166.2 in Q4 2022.
  • Average Interest Expenses over 5 years is -$14767.3, with a median of -$8940.6 recorded in 2022.
  • Year-over-year, Interest Expenses sank 520.95% in 2022 and jumped 78.5% in 2023.
  • Over 5 years, Interest Expenses stood at -$46166.2 in 2022, then increased by 16.97% to -$38333.6 in 2023, then jumped by 42.42% to -$22071.8 in 2024, then rose by 8.03% to -$20299.8 in 2025, then climbed by 16.15% to -$17020.5 in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were -$17020.5 in Q2 2026, -$17337.6 in Q1 2026, and -$20299.8 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -1.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -17,020.46
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17,020.46
Mar 31, 2026 -17,337.57
Dec 31, 2025 -20,299.75
Sep 30, 2025 -16,786.46
Jun 30, 2025 -3,797.72
Mar 31, 2025 -4,298.00
Dec 31, 2024 -22,071.84
Sep 30, 2024 -5,526.24
Jun 30, 2024 -9,403.38
Mar 31, 2024 -5,032.03
Dec 31, 2023 -38,333.59
Sep 30, 2023 -5,330.83
Jun 30, 2023 -5,501.25
Mar 31, 2023 -5,933.43
Dec 31, 2022 -46,166.19
Sep 30, 2022 -6,901.64
Jun 30, 2022 -8,477.77
Mar 31, 2022 -27,593.80
Dec 31, 2021 -28,335.02
Sep 30, 2021 -11,235.07